Literature DB >> 2549320

Receptors for atrial natriuretic peptide (ANP) and regulation of thyroglobulin secretion by ANP in human thyroid cells.

D F Sellitti1, Y C Tseng, L Wartofsky.   

Abstract

Specific binding sites for atrial natriuretic peptide (ANP) were identified and characterized in primary cultures of human thyroid cells. Saturation analysis using [125I] alpha rat ANP as the ligand showed a single class of high affinity binding (Kd = 0.2 nM) which was inhibited by atriopeptin I and the alpha -human form of ANP, but not by a C-terminal fragment of the peptide. The number of ANP binding sites in these cultures was not altered by the thyroid hormone concentration of the medium. In a dose-response experiment, thyro-globulin secretion was significantly reduced in the presence of 0.01 nM ANP and was maximally reduced (to 25% of control value) with 10 nM ANP. Cyclic GMP production was increased threefold in the presence of 100 nM ANP, but was unchanged with lower doses (0.01 and 0.1 nM) of the peptide. The finding of receptors in thyroid follicular cells suggests a hitherto unrecognized role of ANP in the thyroid gland.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549320     DOI: 10.1016/0024-3205(89)90172-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

Review 1.  Atrial natriuretic peptide in peripheral organs other than the heart.

Authors:  A M Vollmar
Journal:  Klin Wochenschr       Date:  1990-07-17

2.  Four cardiac hormones eliminate up to 82% of human medullary thyroid carcinoma cells within 24 hours.

Authors:  Ehrentraud J Eichelbaum; Brian A Vesely; Abdel A Alli; Ying Sun; William R Gower; David L Vesely
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.